Literature DB >> 10712248

A myosin phosphatase targeting subunit isoform transition defines a smooth muscle developmental phenotypic switch.

W P Dirksen1, F Vladic, S A Fisher.   

Abstract

Smooth muscle myosin phosphatase dephosphorylates the regulatory myosin light chain and thus mediates smooth muscle relaxation. The activity of this myosin phosphatase is dependent upon its myosin-targeting subunit (MYPT1). Isoforms of MYPT1 have been identified, but how they are generated and their relationship to smooth muscle phenotypes is not clear. Cloning of the middle section of chicken and rat MYPT1 genes revealed that each gene gave rise to isoforms by cassette-type alternative splicing of exons. In chicken, a 123-nucleotide exon was included or excluded from the mature mRNA, whereas in rat two exons immediately downstream were alternative. MYPT1 isoforms lacking the alternative exon were only detected in mature chicken smooth muscle tissues that display phasic contractile properties, but the isoform ratios were variable. The patterns of expression of rat MYPT1 mRNA isoforms were more complex, with three major and two minor isoforms present in all smooth muscle tissues at varying stoichiometries. Isoform switching was identified in the developing chicken gizzard, in which the exon-skipped isoform replaced the exon-included isoform around the time of hatching. This isoform switch occurred after transitions in myosin heavy chain and myosin light chain (MLC(17)) isoforms and correlated with a severalfold increase in the rate of relaxation. The developmental switch of MYPT1 isoforms is a good model for determining the mechanisms and significance of alternative splicing in smooth muscle.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10712248     DOI: 10.1152/ajpcell.2000.278.3.C589

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  25 in total

1.  Expression of CPI-17 and myosin phosphatase correlates with Ca(2+) sensitivity of protein kinase C-induced contraction in rabbit smooth muscle.

Authors:  T P Woodsome; M Eto; A Everett; D L Brautigan; T Kitazawa
Journal:  J Physiol       Date:  2001-09-01       Impact factor: 5.182

Review 2.  Vascular smooth muscle phenotypic diversity and function.

Authors:  Steven A Fisher
Journal:  Physiol Genomics       Date:  2010-08-24       Impact factor: 3.107

3.  Molecular characterization of myosin phosphatase in endothelium.

Authors:  Kyung-Mi Kim; Csilla Csortos; Istvan Czikora; David Fulton; Nagavedi S Umapathy; Gabor Olah; Alexander D Verin
Journal:  J Cell Physiol       Date:  2012-04       Impact factor: 6.384

Review 4.  Myosin phosphatase isoforms as determinants of smooth muscle contractile function and calcium sensitivity of force production.

Authors:  Rachael P Dippold; Steven A Fisher
Journal:  Microcirculation       Date:  2014-04       Impact factor: 2.628

5.  A bioinformatic and computational study of myosin phosphatase subunit diversity.

Authors:  Rachael P Dippold; Steven A Fisher
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-06-04       Impact factor: 3.619

Review 6.  Mechanisms of Vascular Smooth Muscle Contraction and the Basis for Pharmacologic Treatment of Smooth Muscle Disorders.

Authors:  F V Brozovich; C J Nicholson; C V Degen; Yuan Z Gao; M Aggarwal; K G Morgan
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

7.  Tra2beta as a novel mediator of vascular smooth muscle diversification.

Authors:  Supriya Shukla; Steven A Fisher
Journal:  Circ Res       Date:  2008-07-31       Impact factor: 17.367

Review 8.  Myosin phosphatase target subunit: Many roles in cell function.

Authors:  Fumio Matsumura; David J Hartshorne
Journal:  Biochem Biophys Res Commun       Date:  2007-12-26       Impact factor: 3.575

9.  Par-4: a new activator of myosin phosphatase.

Authors:  Susanne Vetterkind; Eunhee Lee; Eric Sundberg; Ransom H Poythress; Terence C Tao; Ute Preuss; Kathleen G Morgan
Journal:  Mol Biol Cell       Date:  2010-02-03       Impact factor: 4.138

Review 10.  Smooth muscle signalling pathways in health and disease.

Authors:  H R Kim; S Appel; S Vetterkind; S S Gangopadhyay; K G Morgan
Journal:  J Cell Mol Med       Date:  2008-12       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.